Aerie Pharmaceuticals Inc

NORTHERN TRUST CORP

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

457,539

Value ($000)

6,922

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	6,922	0.0%	457,539	9/30/2022
2022 Q2	8/12/2022	3,390	0.0%	451,857	6/30/2022
2022 Q1	5/13/2022	4,021	0.0%	441,856	3/31/2022
2021 Q4	2/8/2022	3,241	0.0%	461,724	12/31/2021
2021 Q3	11/15/2021	5,276	0.0%	462,775	9/30/2021
2021 Q2	8/13/2021	7,687	0.0%	480,138	6/30/2021
2021 Q1	5/12/2021	8,091	0.0%	452,761	3/31/2021
2020 Q4	2/11/2021	6,494	0.0%	480,696	12/31/2020
2020 Q3	11/16/2020	5,810	0.0%	493,690	9/30/2020
2020 Q2	8/14/2020	7,586	0.0%	513,860	6/30/2020
2020 Q1	5/14/2020	7,224	0.0%	535,150	3/31/2020
2019 Q4	2/14/2020	12,808	0.0%	529,888	12/31/2019
2014 Q1	5/14/2014	1,984	0.0%	93,622	3/31/2014
2013 Q4	2/21/2014	1,861	0.0%	103,594	12/31/2013